Shilpa Medicare Ltd.
| BSE: 530549 | Sector: Health care |
| NSE: SHILPAMED | ISIN Code: INE790G01031 |
| BSE 00:00 | 11 Jun | 575.10 |
15.15 (2.71%) |
OPEN
569.00 |
HIGH
579.95 |
LOW
558.80 |
| NSE 00:00 | 11 Jun | 575.35 |
14.80 (2.64%) |
OPEN
570.00 |
HIGH
580.15 |
LOW
558.05 |
| OPEN | 569.00 |
| PREVIOUS CLOSE | 559.95 |
| VOLUME | 58491 |
| 52-Week high | 692.45 |
| 52-Week low | 317.05 |
| P/E | 32.07 |
| Mkt Cap.(Rs cr) | 4,687 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Shilpa Medicare Ltd. (SHILPAMED) - Announcements
-
Shilpa Medicare Ltd RELATED PARTY TRANSACTIONS U/R 29(3)
05/06/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
05/06/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Announcement under Regulation 30 (LODR)-Meeting Updates
01/06/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirem
01/06/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Corporate Action-Board approves Dividend
31/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd RESULTS FOR THE FY 2020-21
31/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Outcome Of Board Meeting - Reg.<BR> Reg 33: Financial Results - Reg. <BR> Ref: Regulatio
31/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Intimation U/R 30 Of The SEBI(LODR) Regulations- Reg
28/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Corporate Action-Board to consider Dividend
25/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obliga
24/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Shilpa Medicare Limited Ties Up With Dr. ReddyS Laboratories Limited For Production Of Sputnik V Vac
17/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd NON APPLICABILITY OF LARGE CORPORATE
14/05/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Intimation U/R 30 Of The SEBI(LODR) Regulations- Reg
26/04/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Compliance Certificate For Half Year Ended 31St March 2021
17/04/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
10/04/2021 | bse
-
Shilpa Medicare Ltd Sub: Compliance Certificate For Half Year Ended 31St March 2021<BR> Ref: Regulation 7(3) Of SEBI (LO
10/04/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Shareholding for the Period Ended March 31 2021
09/04/2021 | bse
-
Shilpa Medicare Ltd Announcement under Regulation 30 (LODR)-Meeting Updates
31/03/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Closure of Trading Window
31/03/2021 | bse |
Downlaod PDF -
Shilpa Medicare Ltd Shilpa Medicare Limited Receives US FDA Tentative Approval For Apremilast Tablets 10 Mg 20 Mg And 30
05/03/2021 | bse |
Downlaod PDF
Quick Links for Shilpa Medicare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
